Last reviewed · How we verify

NCT06845293: CASDEM

AO CSH Mainstream Study on Cervical Spine Degeneration

Not yet recruiting Last updated 25 February 2025
What this trial tests

trial in Cervical Spine Degenerative Disease in 300 participants. Not yet recruiting.

Timeline
1 July 2025
Primary endpoint
31 July 2030
31 July 2035

Quick facts

Lead sponsorAO Innovation Translation Center
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment300
Start date1 July 2025
Primary completion31 July 2030
Estimated completion31 July 2035

Conditions studied

Sponsor

AO Innovation Translation Center

Who can join

18 and older, any sex, with Cervical Spine Degenerative Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adult patients with cervical degenerative diseases undergoing primary anterior and/or posterior cervical fusion will be prospectively enrolled from participating sites. Patients will be treated and followed up at the participating sites per local standard of care. Several variables related to the patient characteristics and fusion details will be collected. The mainstream study will not collect follow-up (FU) data. The duration of this patient cohort is currently planned as open ended.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cervical Spine Degenerative Disease

Currently open trials in the same condition.

Other AO Innovation Translation Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06845293.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing